Could the Withdrawal of Opium Tincture from Iran's Addiction Treatment Program Increase Acute Methadone Poisoning and Mortality?
International Journal of Medical Toxicology and Forensic Medicine,
Vol. 16 (2026),
1 Dey 2026
,
Page 1-3
https://doi.org/10.22037/ijmtfm.v16.53054
Abstract
- Opium Tincture
- Methadone
- Mortality
How to Cite
References
[1] Pirnia B. Opioid agonist treatment in Iran after an opium poppy ban in Afghanistan. Lancet Psychiatry. 2024;11(6):411–2. [DOI: 10.1016/S2215-0366(24)00112-3]
[2] Rostam-Abadi Y, Gholami J, Noroozi A, Rahimi-Movaghar A, et al. Public health risks associated with methadone in Iran: A systematic review and meta-analysis. International Journal of Drug Policy. 2022;100:103529. [DOI: 10.1016/j.drugpo.2021.103529]
[3] Omidvar Tehrani S, Rezaei Ardani A, Akhlaghi S, Shayesteh Zarrin M, Talaei A. Long-term detoxification of opioid use disorder with opium tincture assisted treatment. Front Psychiatry. 2023;14:1273587. [DOI: 10.3389/fpsyt.2023.1273587]
[4] Noroozi A, Rahimi-Movaghar A. Commentary on Nikoo et al.: Challenges in protocol development to optimize outcomes of opium tincture maintenance treatment. Addiction. 2023;118(2):295–6. [DOI: 10.1111/add.16106]
[5] Massah O, Radfar SR, Farhoudian A. Opium Tincture in Iran: Opportunity or Threat? Iranian Journal of Psychiatry and Behavioral Sciences. 2024;18(2):e145989. [DOI:10.5812/ijpbs-145989]
[6] Hadeiy SK, Parhizgar P, Hassanian-Moghaddam H, Zamani N, Khoshkar A, Kolahi AA, Amirabadizadeh A, Rezaei O. Trends of acute drug and chemical toxicities in adults and adolescents in Tehran, Iran between 2012 and 2018: a retrospective chart review. Drug and Chemical Toxicology. 2022;45(5):2039–48. [DOI: 10.1080/01480545.2021.1903486]
- Abstract Viewed: 18 times
- PDF Downloaded: 10 times